BIOGEN INC. Total Operating Expenses 2007-2026 | BIIB
Beta
What is total operating expenses?
Total operating expenses include all costs related to running the core business, including cost of goods sold, R&D, and SG&A.
What is BIOGEN INC.'s current total operating expenses?
BIOGEN INC. (BIIB) annual total operating expenses for 2025 was $8.33B, a 7.26% increase from 2024. BIOGEN INC. total operating expenses for the quarter ending March 31, 2026 was $2.10B.
What was BIOGEN INC.'s total operating expenses in 2024?
BIOGEN INC. annual total operating expenses for 2024 was $7.77B, a 9.00% decline from 2023.
What was BIOGEN INC.'s total operating expenses in 2023?
BIOGEN INC. annual total operating expenses for 2023 was $8.54B, a 29.74% increase from 2022.
What is BIOGEN INC.'s 5-year total operating expenses CAGR?
BIOGEN INC. total operating expenses grew at a compound annual growth rate (CAGR) of 0.15% from FY2020 to FY2025, going from $8.40B to $8.33B over 5 years.
Total Operating Expenses History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-0.2%
FY2020
$8.40B
→
FY2025
$8.33B
07080910111213141516171819202122232425
5 years selected
Total Operating Expenses History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $8.33B | +7.3% | 10-K |
| FY2024 | $7.77B | -9.0% | 10-K |
| FY2023 | $8.54B | +29.7% | 10-K |
| FY2022 | $6.58B | -28.7% | 10-K |
| FY2021 | $9.24B | +10.0% | 10-K |
| FY2020 | $8.40B | +14.5% | 10-K |
| FY2019 | $7.34B | -3.0% | 10-K |
| FY2018 | $7.56B | +9.2% | 10-K |
| FY2017 | $6.93B | +10.0% | 10-K |
| FY2016 | $6.30B | +7.2% | 10-K |
| FY2015 | $5.87B | +2.2% | 10-K |
| FY2014 | $5.75B | +29.4% | 10-K |
| FY2013 | $4.44B | +19.8% | 10-K |
| FY2012 | $3.71B | +11.5% | 10-K |
| FY2011 | $3.32B | -4.1% | 10-K |
| FY2010 | $3.47B | +12.5% | 10-K |
| FY2009 | $3.08B | +6.9% | 10-K |
| FY2008 | $2.88B | +20.6% | 10-K |
| FY2007 | $2.39B | - | 10-K |
Company: BIOGEN INC.Ticker: BIIBSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →